NR3C2 and chronic kidney disease: Considerable evidence supports a pathophysiological role of aldosterone via MR overactivation in CKD and cardiorenal diseases through induction of inflammation and fibrosis that leads to progressive kidney and cardiovascular dysfunction (Bakris et al., 2021; Epstein, 2021).